Is Biomedicine at "Peak Preprint"?
From bioRxiv to medRxiv to PLOS, available data suggest stagnation or disinterest
This post is for paying subscribers only
Already have an account? Sign in.
Subscribe to The Geyser
Don’t miss out on the latest issues. Sign up now to get access to the library of members-only issues.
jamie@example.com
Subscribe